NasdaqCM - Nasdaq Real Time Price USD
Oncternal Therapeutics, Inc. (ONCT)
0.5266
-0.1674
(-24.12%)
As of December 2 at 4:00:00 PM EST. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BREITMEYER JAMES B Chief Executive Officer | Purchase | Apr 14, 2023 | -- |
| HALE DAVID F Director | Purchase | Feb 23, 2024 | -- |
| KAUFMANN GUNNAR F Officer | Purchase | Jun 14, 2023 | 94,726 |
| LEAVITT CHASE C. General Counsel | Purchase | Apr 13, 2023 | 106,901 |
| VINCENT RICHARD G. Chief Financial Officer | Purchase | Apr 13, 2023 | 163,219 |
| WILLS ROBERT JAMES Director | Purchase | Apr 8, 2024 | 10,000 |
| YAZJI SALIM M.D. Officer | Purchase | Apr 14, 2023 | 164,676 |
Related Tickers
27F0.F KALA BIO, Inc.
2.6940
+3.14%
AFMD Affimed N.V.
0.7800
+1.26%
OKUR OnKure Therapeutics, Inc.
2.6700
-3.26%
IKNA Ikena Oncology, Inc.
1.2000
-0.81%
GANX Gain Therapeutics, Inc.
1.8500
0.00%
STTK Shattuck Labs, Inc.
0.8513
0.00%
GYRE Gyre Therapeutics, Inc.
9.20
+0.11%
ADCT ADC Therapeutics SA
1.3300
+3.10%
IPHA Innate Pharma S.A.
1.9700
0.00%
TRDA Entrada Therapeutics, Inc.
8.73
+0.23%